Luigi Mangione has pleaded guilty to federal charges stemming from the killing of UnitedHealthcare CEO Brian Thompson, formally acknowledging in court that he planned and carried out the shooting in Manhattan.
Mangione, 28, appeared in federal court in New York as members of Thompson’s family watched from the courtroom. During his statement to the judge, Mangione described how he allegedly posed as a potential investor and contacted UnitedHealthcare to learn where an investor conference would take place.
He admitted that he had intended to locate Thompson and kill him.
Mangione told the court that he understood his actions could cause Thompson to fear for his life and acknowledged that he knew the shooting was illegal. He also said his decision was influenced by his own experience with the American healthcare system following a back injury.
Prosecutors have previously said Mangione had no personal relationship with Thompson and was not a UnitedHealthcare customer.
The guilty plea resolves the federal charges but does not end the broader criminal case against him. Mangione still faces serious charges in New York state court, creating the possibility of another major legal battle.
Luigi Mangione Faces Federal Sentencing
The federal charges against Mangione involve interstate stalking resulting in death and stalking through interstate facilities resulting in death. Each carries severe penalties, with prosecutors recommending a prison term of roughly 24 to 30 years.
Mangione is scheduled to be sentenced at a separate hearing on December 18. The final punishment will be determined by the judge, who has broad discretion under federal sentencing rules.
During the hearing, Mangione confirmed that he understood the consequences of pleading guilty. He acknowledged that he was giving up his right to have a jury determine his guilt and understood that a federal conviction could affect several of his civil rights, including his ability to vote, own a firearm and serve on a jury.
He also told the court that he had not previously been treated for a mental illness. Mangione said he was clear-headed during the proceedings, although he acknowledged taking a sleep medication in recent days.
Luigi Mangione’s State Murder Case
Mangione’s federal guilty plea is likely to become an important part of the continuing legal fight in New York state court. He remains charged with second-degree murder and firearms-related offenses in connection with Thompson’s death. His state trial is scheduled to begin September 8 unless the proceedings are delayed by the latest legal developments.
Mangione’s defense team is expected to argue that continuing with the state prosecution after the federal case has been resolved could violate double jeopardy protections. His attorney has already filed a motion seeking dismissal of the state charges.
The issue could become complicated if prosecutors challenge the defense argument. A ruling in either direction could potentially lead to additional appeals and prolong a case that has already attracted enormous public attention.
The federal and state cases involve separate charges and jurisdictions, but the defense maintains that they arise from the same underlying conduct.
What Led to the UnitedHealthcare CEO Shooting?
Thompson was fatally shot on December 4, 2024, outside a Manhattan hotel where UnitedHealthcare was holding an investor conference.
Authorities arrested Mangione five days later at a McDonald’s restaurant in Pennsylvania.
Investigators said they recovered a notebook from Mangione’s backpack that contained writings expressing anger and grievances toward the healthcare industry. Authorities also found evidence at the crime scene that appeared to reference the words “delay,” “deny” and “depose.”
The shooting quickly became a national flashpoint because of widespread public frustration with the American health insurance system, particularly disputes involving denied claims and access to medical care.
Thompson, who was the head of one of the country’s largest health insurers, became the focus of intense public debate following his death. His family has largely avoided the spotlight since the shooting, while authorities have also investigated threats directed toward relatives.
Mangione’s lawyers previously challenged the use of the notebook as evidence, arguing that it was obtained through an unlawful search. Courts rejected those arguments in both the federal and state proceedings.
A Guilty Plea With Wider Consequences
Mangione’s decision to plead guilty in federal court brings some clarity to one portion of the case, but it does not resolve the legal questions surrounding the state prosecution.
For prosecutors, the plea establishes Mangione’s responsibility for the conduct covered by the federal charges and removes the need for a federal trial on those counts.
For the defense, however, the focus now shifts to preventing a second prosecution in New York and determining whether the state’s murder case can proceed.
The case also continues to carry significance beyond the courtroom. Thompson’s killing exposed deep public anger toward the health insurance industry, while the investigation and subsequent prosecution have generated intense debate over the boundaries between criticism of healthcare companies and criminal violence.
Mangione’s guilty plea therefore marks a major development, but it is unlikely to be the final chapter. His federal sentence, the pending New York charges and the double jeopardy dispute could keep the case before the courts for months to come.
Luigi Mangione has admitted responsibility in the federal case involving Brian Thompson’s killing, but his legal battle is far from over. With a federal sentencing hearing ahead and a separate murder prosecution still pending in New York, the next major question is whether the state case will survive the defense’s double jeopardy challenge.
